Cefdinir - Oral products
Recognized Interpretive Criteria
Additional FDA-Identified Interpretive Criteria
| Minimum Inhibitory | Disk Diffusion | ||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Haemophilus influenza | M100 standard is recognized | |||||
Streptococcus pneumoniae | M100 standard is recognized | |||||
Streptococcus spp β- | ≤ 1 | 2 | ≥ 4 | ≥ 20 | 17 - 19 | ≤ 16 |
Moraxella catarrhalis | ≤ 1 | 2 | ≥ 4 | ≥ 20 | 17 - 19 | ≤ 16 |
S = Susceptible; I = Intermediate; R = Resistant
Exception to the recognized standard of CLSI M100
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Enterobacteriaceae